Regenerative Medicine: Improving the Way We Live, Play and Feel
ARMI’s Chief Regulatory Officer, Dr. Richard McFarland will present at the New York Tech’s 2023 Biotechnology Conference: Regenerative Medicine: Improving the Way We Live, Play and Feel.
The conference will gather recognized leaders, top global researchers, and medical professionals, plus innovators in the healthcare and biotechnology sectors. Companies and New York Tech faculty will describe their latest state-of-the-art innovations and cutting-edge research transforming and improving the human condition. Government officials and investors will discuss how to tap into financial resources to fund your startup and accelerate your company’s growth. This is a must-attend event for experts, industry peers, and like-minded people to form new relationships and strengthen existing ones.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
